Centene Corporation filings document operating and financial disclosures for a government-focused managed care company. Form 8-K reports furnish quarterly results press releases, GAAP and adjusted EPS guidance, non-GAAP financial measure disclosures, conference-related Regulation FD updates and material-event reports tied to company performance.
Centene's proxy and governance filings cover annual meeting matters, board and executive compensation disclosures, equity awards, officer appointments and related corporate governance topics. Other filings address material agreements, forward-looking-statement disclosures and formal exhibits filed or furnished with the SEC.
Centene Corporation (CNC) reported third-quarter 2026 total revenues of $50.647 billion, compared with $49.690 billion in the prior-year quarter. It recorded a GAAP diluted loss of $0.14 per share and adjusted diluted earnings of $0.58 per share; adjusted net earnings were $290 million, versus $245 million a year earlier. The health benefits ratio was 92.7%, unchanged from a year earlier.
Centene raised its 2026 GAAP diluted EPS guidance floor to greater than $3.46 and its adjusted diluted EPS floor to greater than $5.20, an increase of $0.40 in adjusted EPS guidance. It lowered its HBR guidance range to 90.4% to 91.1% and its interest expense guidance range to $600 million to $620 million. Third-quarter cash flow used in operations was $3.669 billion; Centene said the outflow primarily reflected the timing of pass-through, premium and other payments, as expected.
Debt was reduced by $1.1 billion since June 30, 2026, and Centene repurchased the remaining $569 million of its 2027 senior notes in October. Total debt was $15.5 billion at September 30, 2026, and cash available for general corporate use was $175 million.
Centene Corporation reported third-quarter 2026 total revenues of $50.647 billion, compared with $49.690 billion a year earlier. Net loss attributable to Centene was $71 million, or $0.14 per diluted share; adjusted net earnings were $290 million and adjusted diluted EPS was $0.58, versus $245 million and $0.50. The health benefits ratio was 92.7%, unchanged year over year; the SG&A expense ratio was 7.2%, versus 7.0%, while the adjusted SG&A expense ratio was 6.5%, versus 7.0%.
For the first nine months, total revenues were $154.170 billion versus $145.052 billion, and net earnings attributable to Centene were $2.561 billion versus a $5.573 billion loss. Net cash provided by operating activities was $4.287 billion, compared with $4.651 billion. Third-quarter operating cash flow used $3.7 billion, driven by the timing of pass-through payments.
Managed-care membership was 25.7 million, down 2.3 million, or 8%, year over year. Centene repurchased $1.847 billion par value of 2027 and 2028 senior notes for $1.837 billion during the first nine months. Effective January 1, 2027, California will transition the Medi-Cal UIS population from managed care to fee-for-service; approximately 175,000 members served through Health Net's at-risk Medi-Cal contracts are expected to be affected, with California Medicaid membership and associated premium revenue expected to decline.
Centene Corp Group President, Medicare&Spec, Michael A. Carson, had 7,130 shares withheld for taxes upon vesting of previously reported restricted stock units on October 15, 2026. The reported price was $70.16 per share. His direct holdings after the transaction were 115,752 shares, including 99,734 restricted stock units and performance stock units subject to vesting requirements; he also reported 825 shares held indirectly by his spouse. No Rule 10b5-1 plan is reported.
Centene Corporation (CNC) delivered a notice to redeem on October 23, 2026, all remaining $568,664,000 aggregate principal amount of its outstanding 4.25% Notes due December 15, 2027. The redemption price is 100% of principal plus accrued and unpaid interest, if any, to but excluding the redemption date.
Centene Corp. (CNC) director Lauren M. Tyler received an award of 482 common shares on September 30, 2026. The reported price was $0 per share; this was a grant award rather than a market purchase. Her direct holdings after the transaction were 3,698 shares, including 3,155 previously granted restricted stock units subject to vesting requirements.
Centene Corp. (CNC) director Kenneth Tanji acquired 603 shares of common stock through a grant on September 30, 2026. His reported direct holdings after the transaction were 13,093 shares; the ownership total includes 3,992 shares of previously granted restricted stock units subject to vesting requirements.
Theodore R. Samuels II, a Centene Corp. director, acquired 583 shares of common stock through a grant/award on September 30, 2026; the reported price was $0.00 per share. His reported direct holdings following the award were 25,796 shares, including 3,992 previously granted restricted stock units subject to vesting requirements. A revocable family trust of which Samuels is a co-trustee held 32,000 shares indirectly.
Centene Corp. (CNC) director Frederick H. Eppinger acquired 864 shares of common stock as a grant on September 30, 2026. His reported direct position after the award was 370,402 shares, including 6,654 shares of previously granted restricted stock units subject to vesting requirements.
Centene Corp. (CNC) director Christopher J. Coughlin received an award of 583 common shares on September 30, 2026. His reported direct ownership after the award was 19,294 shares, including 3,992 previously granted restricted stock units subject to vesting requirements. He also reported indirect ownership of 30,054 shares held by a grantor retained annuity trust for his benefit and his adult children; he is the trust’s sole trustee.
CENTENE CORP (CNC) reported that Corporate Controller & CAO Theodore J. Pienkos had 1,092 shares of common stock withheld on September 15, 2026 to pay tax liabilities upon vesting of a previously reported restricted stock unit grant. After this withholding, he holds 28,751.493 shares directly, including 13,763 restricted and performance stock units subject to vesting requirements. No Rule 10b5-1 trading plan is reported.